Coloplast
Coloplast AS is a Denmark-based medical device manufacturer that develops and markets products for intimate healthcare needs. The company's global operations are structured into four primary business segments: Ostomy Care, Continence Care, Wound and Skin Care, and Interventional Urology. Revenue is predominantly generated from the sale of single-use medical consumables, including ostomy bags, urinary catheters, advanced dressings, and surgical implants. Its principal end market comprises hospitals, home healthcare providers, pharmacies, and individual end-users living with chronic conditions. The company distributes its medical products across more than one hundred countries through proprietary sales entities and distributor networks. Coloplast holds the leading global market share position in both the ostomy care and continence care product segments. The company is headquartered in Humlebaek, Denmark, and its shares are listed on Nasdaq Copenhagen.
66 of the funds FundTelligence covers report a position in Coloplast.
- Legal name
- Coloplast AS
- Sector
- Health Care
- Country
- Denmark
- Funds holding it
- 66
Funds holding Coloplast
- Holberg Norden — Holberg · 4.48 % (full portfolio disclosed, October 2026)
- Danske Invest Denmark Focus — Danske Invest · 4.45 % (full portfolio disclosed, September 2026)
- Nordnet Danmark Indeks — Nordnet · 3.24 % (full portfolio disclosed, October 2026)
- Protean Aktiesparfond Norden — Protean · 3.09 % (full portfolio disclosed, June 2026)
- Handelsbanken Norden Selektiv — Handelsbanken · 1.96 % (full portfolio disclosed, October 2026)
- Aktie-Ansvar Europa — Aktie-Ansvar · 1.93 % (full portfolio disclosed, June 2026)
- Heimdal Norden Utbytte — Heimdal Fondene · 1.91 % (full portfolio disclosed, October 2026)
- Handelsbanken Norden — Handelsbanken · 1.9 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 66 funds holding it.